Predictive Value of Glycemic Variability and HDL-C for Secondary Persistent Inflammatory Immunosuppressed Catabolic Syndrome in Patients with Sepsis

References

• Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi:10.1164/rccm.201504-0781OC
   PubMed Web of Science ®Google Scholar
• Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–1562. doi:10.1007/s00134-020-06151-x
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2(1):16045. doi:10.1038/nrdp.2016.45
   PubMed Web of Science ®Google Scholar
• Hawkins RB, Raymond SL, Stortz JA, et al. Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome. Front Immunol. 2018;9:1511. doi:10.3389/fimmu.2018.01511
   PubMed Web of Science ®Google Scholar
• Meegan A, Rosielle DA. Chronic critical illness in adults #343. J Palliat Med. 2018;21(1):99–100. doi:10.1089/jpm.2017.0546
   PubMed Web of Science ®Google Scholar
• Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–1501. doi:10.1097/TA.0b013e318256e000
   PubMed Web of Science ®Google Scholar
• Bergmann CB, Beckmann N, Salyer CE, et al. Lymphocyte immunosuppression and dysfunction contributing to persistent inflammation, immunosuppression, and catabolism syndrome (pics). Shock. 2021;55(6):723–741. doi:10.1097/SHK.0000000000001675
   PubMed Web of Science ®Google Scholar
• Preechasuk L, Suwansaksri N, Ipichart N, et al. Hyperglycemia and glycemic variability are associated with the severity of sepsis in nondiabetic subjects. J Crit Care. 2017;38:319–323. doi:10.1016/j.jcrc.2016.12.005
   PubMed Web of Science ®Google Scholar
• Barker G, Leeuwenburgh C, Brusko T, et al. Lipid and lipoprotein dysregulation in sepsis: clinical and mechanistic insights into chronic critical illness. J Clin Med. 2021;10(8):1693. doi:10.3390/jcm10081693
   PubMed Web of Science ®Google Scholar
• Cirstea M, Walley KR, Russell JA, et al. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. J Crit Care. 2017;38:289–294. doi:10.1016/j.jcrc.2016.11.041
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Mira JC, Brakenridge SC, Moldawer LL, et al. Persistent inflammation, immunosuppression and catabolism syndrome. Crit Care Clin. 2017;33(2):245–258. doi:10.1016/j.ccc.2016.12.001
   PubMed Web of Science ®Google Scholar
• Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45(2):253–262. doi:10.1097/CCM.0000000000002074
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Konishi K, Tsunoda T, et al. Significance of glycemic variability in diabetes mellitus. Intern Med. 2022;61(3):281–290. doi:10.2169/internalmedicine.8424-21
   PubMed Web of Science ®Google Scholar
• Yu WK, Li WQ, Li N, et al. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003;9(8):1824–1827. doi:10.3748/wjg.v9.i8.1824
   PubMed Web of Science ®Google Scholar
• Plummer MP, Deane AM. Dysglycemia and glucose control during sepsis. Clin Chest Med. 2016;37(2):309–319. doi:10.1016/j.ccm.2016.01.010
   PubMed Web of Science ®Google Scholar
• Lin S, Lai D, He W. Association between hyperglycemia and adverse clinical outcomes of sepsis patients with diabetes. Front Endocrinol (Lausanne). 2022;13:1046736. doi:10.3389/fendo.2022.1046736
   PubMedGoogle Scholar
• Xiao F, Wang Y, Lin H, et al. predictive value of glycosylated serum protein combined with glycemic variability on secondary persistent inflammatory immunosuppressed catabolic syndrome prediction in elderly septic patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(11):1051–1055. doi:10.3760/cma.j.issn.2095-4352.2018.011.008
   PubMedGoogle Scholar
• Barker G, Winer JR, Guirgis FW, et al. HDL and persistent inflammation immunosuppression and catabolism syndrome. Curr Opin Lipidol. 2021;32(5):315–322. doi:10.1097/MOL.0000000000000782
   PubMed Web of Science ®Google Scholar
• Aleman L, Guerrero J. sepsis hyperglycemia in the ICU: from the mechanism to the clinic. Rev Med Chil. 2018;146(4):502–510. doi:10.4067/s0034-98872018000400502
   PubMed Web of Science ®Google Scholar
• Trinder M, Walley KR, Boyd JH, et al. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease. Arterioscler Thromb Vasc Biol. 2020;40(1):267–278. doi:10.1161/ATVBAHA.119.313381
   PubMed Web of Science ®Google Scholar
• Li X, Zhang D, Chen Y, et al. Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis. Diabetol Metab Syndr. 2022;14(1):59. doi:10.1186/s13098-022-00819-8
   PubMed Web of Science ®Google Scholar
• Li H, Liu W, Su W, et al. Changes in plasma HDL and its subcomponents hdl2b and hdl3 regulate inflammatory response by modulating socs1 signaling to affect severity degree and prognosis of sepsis. Infect Genet Evol. 2021;91:104804. doi:10.1016/j.meegid.2021.104804
   PubMed Web of Science ®Google Scholar
• Trinder M, Wang Y, Madsen CM, et al. Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis. Circulation. 2021;143(9):921–934. doi:10.1161/CIRCULATIONAHA.120.048568
   PubMed Web of Science ®Google Scholar
• Fitrolaki DM, Dimitriou H, Kalmanti M, et al. Cd64-neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMC Pediatr. 2013;13:31. doi:10.1186/1471-2431-13-31
   PubMed Web of Science ®Google Scholar